Atrial natriuretic peptide influence on nitric oxide system in kidney and heart

Regulatory Peptides

Volumn 118, Issue 3, 2004, Pages 151-157

  De Los Ángeles Costa, María ^a   Elesgaray, Rosana ^a   Loria, Analía ^a   Balaszczuk, Ana María ^a   Arranz, Cristina ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Atria; Nitric oxide; Nitric oxide synthase; Renal cortex; Renal medulla; Ventricle

Indexed keywords

ARGININE; ATRIAL NATRIURETIC FACTOR; CITRULLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; DIURESIS; ENZYME ACTIVITY; GLOMERULUS; HEART; HEART ATRIUM; HEART LEFT VENTRICLE; HEART RIGHT ATRIUM; HEART VENTRICLE; HEMODYNAMICS; HYPOTENSION; KIDNEY; KIDNEY COLLECTING TUBULE; KIDNEY PROXIMAL TUBULE; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ATRIAL NATRIURETIC FACTOR; HEART; HEART ATRIA; HEART VENTRICLES; HISTOCYTOCHEMISTRY; KIDNEY; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MYOCARDIUM; NADPH DEHYDROGENASE; NEPHRONS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR;

EID: 1542300871     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2003.12.009     Document Type: Article

References (52)

1. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
2. Wilkins M.R., Redondo J., Brown L.A. The natriuretic peptide family. Lancet. 349:1997;1307-1310.
3. 2+-independent activation of the endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. 96:1999;1123-1128.
4. Maack T. Role of atrial natriuretic factor in volume control. Kidney Int. 49:1996;1732-1737.
5. Waldmann S.A., Murad F. Atrial natriuretic peptides: receptors and second messengers. Bioassays. 10:1989;16-19.
6. Maack T. Receptors of atrial natriuretic factor. Annu. Rev. Physiol. 54:1992;11-27.
7. Brenner B.M., Ballermann B.J., Gunning M.E., Zeidel M.L. Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70(3):1990;665-699.
8. Nuñez D.J.R., Dickson M.C., Brown M.J. Natriuretic peptide receptor messenger RNAs in the rat and human heart. J. Clin. Invest. 90:1992;1966-1971.
9. Totsune K., Takahashi H., Murakami O., Satoh F., Sone M., Saito T.et al. Natriuretic peptides in the human kidney. Hypertension. 74:1994;758-762.
10. Lin X., Hanze J., Heese F., Sodman R., Lang R.E. Gene expression of natriuretic peptide receptors in myocardial cells. Circ. Res. 77:1995;750-758.
11. Beltowski J., Wojcicka G. Regulation of renal tubular transport by cardiac natriuretic peptides: two decades of research. Med. Sci. Monit. 8(2):2002;RA39-RA52.
12. Cooke J.P., Dzau V.J. Nitric oxide synthase: role in the genesis of vascular disease. Annu. Rev. Med. 48:1997;489-509.
13. Murad F. Discovery of some of the biological effects of nitric oxide and its role in cell signalling. Biosci. Rep. 19:1998;133-154.
14. Welch W.J., Wilcox C.S., Thomson S.C. Nitric oxide and tubulo-glomerular feedback. Semin. Nephrol. 19(3):1999 (May);251-262.
15. De Forstermann U., Schmidt H.W., Pollock J.S., Sheng H., Mitchell J.A., Warner T.D.et al. Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem. Pharmacol. 42:1991;1849-1857.
16. G-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release. Endocrinology. 136(3):1995;1241-1249.
17. Skvorak J.P., Dietz J.R. Endothelin and nitric oxide interact to regulate stretch-induced ANP secretion. Am. J. Physiol. 273(1 Pt 2):1997;R301-R306.
18. Gyurko R., Kuhlencordt P., Fishman M.C., Huang L.H. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am. J. Physiol., Heart Circ. Physiol. 278:2000;H971-H981.
19. Costa M.A., Gonzalez Bosc L.V., Majowicz M.P., Vidal N.A., Balaszczuk A.M., Arranz C.T. Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats. Hypertension. 35:2000;1119-1123.
20. Rothe F., Canzler U., Wolf G. Subcellular localization of the neuronal isoform of nitric oxide synthase in the rat brain: a critical evaluation. Neuroscience. 83:1998;259-269.
21. Stuehr D.J., Fasehum O.A., Kwon N.S., Gross S.S., Gonzalez J.A., Levi R.et al. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J. 5:1991;98-103.
22. Stuehr D.J., Cho H.J., Kwon N.S., Weise M., Nathan C.F. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: a FAD- and FMN-contain flavoprotein. Proc. Natl. Acad. Sci. U. S. A. 88:1991;7773-7777.
23. Vincent S., Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 46:1992;755-784.
24. Rosignoli F., Pérez Leirós C. Activation of nitric oxide synthase through muscarinic receptors in rat parotid gland. Eur. J. Pharmacol. 439:2002;27-33.
25. Pérez Leirós C., Rosignoli F., Genaro A.M., Sales M.E., Sterin-Borda L., Borda E.S. Differential activation of nitric oxide synthase through muscarinic acetylcholine receptors in rat salivary glands. J. Auton. Nerv. Syst. 79:2000;99-107.
26. Dunn B.R., Ichikawa I., Pteffer J.M., Troy J.L., Brenner B.M. Renal and systemic hemodynamic effect of synthetic atrial natriuretic peptide in the anesthetized rat. Circ. Res. 59:1986;237-246.
27. Appel R.G., Wang J., Simonson M.S., Dunn M.J. A mechanism by which atrial natriuretic factor mediates its glomerular actions. Am. J. Physiol. 251:1986;F1036-F1042.
28. Itoh K., Nonoguchi H., Shiraishi N., Tomita K. Gene regulation of atrial natriuretic peptide A, B and C receptors in rat glomeruli. Exp. Nephrol. 7(4):1999;328-336.
29. Granger J.P., Alexander B.T. Abnormal pressure-natriuresis in hypertension: role of nitric oxide. Acta Physiol. Scand. 168:2000;161-168.
30. McLay J.S., Chatterjee P.K., Jardine A.G., Hawksworth G.M. Atrial natriuretic factor modulates nitric oxide production: an ANF-C receptor-mediated effect. J. Hypertens. 13:1995;625-630.
31. McLay J.S., Chatterjee P.K., Mistry S.K., Weerakoby R.P., Jardine A.G., McKay N.G.et al. Atrial natriuretic factor and angiotensin II stimulate nitric oxide release from human proximal tubular cells. Clin. Sci. (Lond.). 89:1995;527-531.
32. Aperia A.G. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu. Rev. Physiol. 62:2000;621-647.
33. Holtback U., Kruse M.S., Brismar H., Aperia A. Intrarenal dopamine coordinates the effect of antinatriuretic and natriuretic factors. Acta Physiol. Scand. 168:2000;215-218.
34. Costa M.A., Loria A., Marchetti M., Balaszczuk A.M., Arranz C.T. Effects of dopamine and nitric oxide on arterial pressure and renal function in volume expansion. Clin. Exp. Pharmacol. Physiol. 29(9):2002;772-776.
35. Rouch A.J., Chen L., Troutman S.L., Schafer J.A. Na+ transport in the isolated rat CCD: effects of bradykinin, ANP, clonidine and hydrochlorothiazide. Am. J. Physiol. 260:1991;F86-F95.
36. Schlatter E., Cermak R., Forssmann W.G. cGMP-activating peptides do not regulate electrogenic electrolyte transport in the principal cells of the rat CCD. Am. J. Physiol. 271:1996;F1158-F1165.
37. Nonoguchi H., Sands J.M., Knepper M.A. ANP inhibits NaCl and fluid absorption in cortical collecting duct of rat kidney. Am. J. Physiol. 256:1989;F179-F186.
38. Terada Y., Moriyama T., Martin B.M., Knepper M.A., Garcia-Perez A. RT-PCR microlocalization of mRNA for guanylyl cyclase-coupled ANP receptor in rat kidney. Am. J. Physiol. 261:1991;F1080-F1087.
39. Zeidel M.L., Silva P., Brenner B.M., Scifter J.L. Cyclic GMP mediates effects of atrial peptides on medullary collecting duct cells. Am. J. Physiol. 252:1987;F551-F559.
40. McCoy D.E., Guggino S.E., Stanton B.A. The renal cGMP-gated cation channel: its mollecular structure and physiological role. Kidney Int. 48:1995;1125-1133.
41. Kishimoto J., Dubois S.K., Garbers D.L. The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion. Proc. Natl. Acad. Sci. U. S. A. 93:1996;6215-6219.
42. Ishikawa S., Saito T., Okada K., Kuzuya T., Kangawa K., Matsuo H. Atrial natriuretic factor increases cyclic GMP and inhibit cyclic AMP in rat renal papillary. Biochem. Biophys. Res. Commun. 130:1985;1147-1153.
43. Cantiello H.F., Ausiello D.A. Atrial natriuretic factor and cGMP inhibit amiloride-sensitive-Na+ transport in cultured renal epithelial cell line, LLC-PK1. Biochem. Biophys. Res. Commun. 134:1986;852-860.
44. +-ATPase inhibition by atrial natriuretic factor in rat renal medulla. J. Physiol. Pharmacol. 49:1998;271-283.
45. McKee M., Scavone C., Nathanson J.A. Nitric oxide, cGMP and hormone regulation of active sodium transport. Proc. Natl. Acad. Sci. U. S. A. 91:1994;I2056-I2060.
46. +-ATPase in opossum kidney cells. Kidney Int. 56:1999;527-634.
47. +-ATPase activity by angiotensin II in rat proximal tubules. Am. J. Physiol. 280:2001;F474-F479.
48. Nunez D.J., Dickson M.C., Brown M.J. Natriuretic peptide receptor mRNAs in the rat and human heart. J. Clin. Invest. 90:1992;1966-1971.
49. Nachshon S., Zamir O., Matsuda Y., Zamir N. Effects of ANP receptor antagonists on ANP secretion from adult rat cultured atrial myocytes. Am. J. Physiol., Endocrinol. Metab. 268:1995;E428-E432.
50. Lainchbury J.G., Burnett J.C., Meyer D., Redfield M.M. Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs. Am. J. Physiol., Heart Circ. Physiol. 278:2000;H33-H40.
51. Hare J.M., Stamler J.S. NOS: modulator, not mediator of cardiac performance. Nat. Med. 5:1999;273-274.
52. Ortiz P.A., Garvin J.L. Cardiovascular and renal control in NOS-deficient mouse models. Am. J. Physiol., Regul. Integr. Comp. Pysiol. 284:2003;628-638.